ecrin-mdr-crcClinical2016colorectal cancerColorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2636857Japan3ECRIN MDRRecruitingfalseExploratory study for prevention of nausea and vomiting switching from Granisetron + Dexamethasone (Day1-3) + Aprepitant (Day1-3) to Palonosetron + Dexamethasone (Day1) in patients given moderately emetogenic chemotherapyInterventions: GRA+DEX (Day1-3)+APR(Day1-3) PALO+DEX(Day1) Primary outcome(s): Nausea (Overall study period) Study Design: Single arm Non-randomized2016-03-152636857JPRN-UMIN000021593